Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierWe are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples. Our products and solutions address the rapidly evolving needs of a diverse array of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Q1 2026 · $823.4MThe company’s own SEC segment disclosure.
- Bsi Calid$316.3M38%
- Bsi Nano$246.0M30%
- Bsi Biospin$197.5M24%
- Energy And Supercon Technologies$63.6M8%
Bruker Corporation (BRKR) reported revenue of $823M in Q1 2026 (quarter ended March 31, 2026), up 2.7% from the same quarter a year earlier. That came with a gross margin of 46% and net income of $14M (1.7% of revenue). For the full year FY2025, revenue was $3.44B (+2.1% year on year) and net income −$8.6M. Its largest segment in 2026-Q1 was Bsi Calid at $316M, 38% of the disclosed total, just ahead of Bsi Nano at 30%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.